Viewing Study NCT06697366


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2025-12-24 @ 4:08 PM
Study NCT ID: NCT06697366
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-20
First Post: 2024-11-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module